These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21896761)

  • 1. Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics.
    Smirnov I; Carletti E; Kurkova I; Nachon F; Nicolet Y; Mitkevich VA; Débat H; Avalle B; Belogurov AA; Kuznetsov N; Reshetnyak A; Masson P; Tonevitsky AG; Ponomarenko N; Makarov AA; Friboulet A; Tramontano A; Gabibov A
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15954-9. PubMed ID: 21896761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
    Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malachite green mediates homodimerization of antibody VL domains to form a fluorescent ternary complex with singular symmetric interfaces.
    Szent-Gyorgyi C; Stanfield RL; Andreko S; Dempsey A; Ahmed M; Capek S; Waggoner AS; Wilson IA; Bruchez MP
    J Mol Biol; 2013 Nov; 425(22):4595-613. PubMed ID: 23978698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28.
    Tan P; Mitchell DA; Buss TN; Holmes MA; Anasetti C; Foote J
    J Immunol; 2002 Jul; 169(2):1119-25. PubMed ID: 12097421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.
    Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J
    J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical basis for the affinity maturation of a camel single domain antibody.
    De Genst E; Handelberg F; Van Meirhaeghe A; Vynck S; Loris R; Wyns L; Muyldermans S
    J Biol Chem; 2004 Dec; 279(51):53593-601. PubMed ID: 15383540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
    Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
    J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
    Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
    Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
    Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
    FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.
    Choi DK; Bae J; Shin SM; Shin JY; Kim S; Kim YS
    MAbs; 2014; 6(6):1402-14. PubMed ID: 25484049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical properties of human antibody variable domains.
    Ewert S; Huber T; Honegger A; Plückthun A
    J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M; Plückthun A
    J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.